In 2014, Gueye et al. [26] conducted studies whose results suggest that SS patients with Hp2-2 genotype exhibited significantly lower Hb means compared to Hp1-1 and Hp2-1 subjects. This evidence concerns the gene GSTM1 and synovial sarcoma.